Mature results of neoadjuvant chemotherapy followed by radiotherapy in nasopharyngeal cancer: Is it really old fashioned?

Medical Oncology

Volumn 25, Issue 1, 2008, Pages 93-99

  Kamer, Serra ^a   Esassolak, Mustafa ^a   Yalman, Deniz ^a   Karabulut, Bulent ^a   Bolukbasi, Yasemin ^a   Aydin, Barbaros ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Long term survival; Nasopharyngeal cancer; Neoadjuvant chemotherapy; Prognostic factors; Radiotherapy

Indexed keywords

BLEOMYCIN; CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TOXICITY; BONE MARROW TOXICITY; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CANCER; NAUSEA AND VOMITING; NEPHROTOXICITY; PANCREAS CANCER; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT RESPONSE; TRISMUS; XEROSTOMIA; ADJUVANT CHEMOTHERAPY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NASOPHARYNX TUMOR;

ADOLESCENT; ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PROGNOSIS;

EID: 42949155887     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-007-0052-6     Document Type: Article

References (29)

1. M Altun A Fandi O Dupuis 1995 Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects Int J Radiat Oncol Biol Phys 32 859 77
2. FB Geara G Sanguineti SL Tucker 1997 Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival Radiother Oncol 43 53 61
3. DT Chua JST Sham GKH Au 2002 Concomitant chemo-irradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: results of a matched-cohort analysis Int J Radiat Oncol Biol Phys 53 334 43
4. Frei E 3rd. What's in a name- neoadjuvant. J Natl Cancer Inst 1988;21:1088-9.
5. Hall EJ. Radiobiology for the radiologist. Chapter 1. Philadelphia: Lipincott Williams and Wilkins; 2000.
6. DT Chua JST Sham D Choy 1998 Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma Cancer 83 2270 83
7. J Ma HQ Mai MH Hong 2001 Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma J Clin Oncol 19 1350 57
8. M Hareyama K Sakata H Shirato 2002 A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma Cancer 94 2217 23
9. AT Chan PM Teo TW Leung 1995 A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 33 569 77
10. JC Lin WM Liang JS Jan 2004 Another way to estimate outcome of advanced nasopharyngeal carcinoma-is concurrent chemoradiotherapy adequate? Int J Radiat Oncol Biol Phys 60 156 64
11. DT Chua J Ma JS Sham 2005 Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials J Clin Oncol 23 1118 24
12. DT Chua J Ma J Sham 2006 Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: subgroup analysis of two phase III trials Int J Radiat Oncol Biol Phys 65 1300 6
13. JA Langendijk CR Leemans J Buter 2004 The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature J Clin Oncol 22 4604 12
14. E Cvitkovic 1997 UNCT: chemocurable sometimes, but not very often Ann Oncol 8 723 5
15. AB Miller B Hoogstraten M Staquet 1981 Reporting results of cancer treatment Cancer 47 207 14
16. JD Cox J Stetz TF Pajak 1995 Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1341 6
17. M Al-Sarraf M LeBlanc PG Giri 1998 Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 J Clin Oncol 16 1310 7
18. JC Lin JS Jan CY Hsu 2003 Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival J Clin Oncol 21 631 7
19. AT Chan SF Leung RK Ngan 2005 Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma J Natl Cancer Inst 97 536 9
20. J Wee EH Tan BC Tai 2005 Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety J Clin Oncol 23 6730 8
21. ATC Chan PML Teo RK Ngan 2002 Concurrent chemotherapy radiotherapy compared with radiotherapy alone in loco-regionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial J Clin Oncol 20 2038 44
22. International Nasopharynx Cancer Study Group 1996 VUMCA I trial: preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival Int J Radiat Oncol Biol Phys 35 463 9
23. FM Johnson A Garden JL Palmer et al. 2004 A phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status Cancer 100 5 991 8
24. A Garden 2005 Is there still a role for induction chemotherapy for head and neck cancer? J Clin Oncol 23 1059 60
25. Remenar E, Herpen VC, Lluch GJ, et al. A randomized phase III multicenter trial of neoadjuvant docetaxel (Taxotere) plus cisplatin plus 5-fluorouracil (TPF) versus neoadjuvant cisplatin plus 5-fluororuacil (PF) in patients with locally advanced unresectable squamous cell carcinoma of the head and neck (SCCHN): final analysis of EORTC protocol 24971. J Clin Oncol 2006;24:5516 (abstract).
26. R Hitt A Lopez-Pousa J Martinez-Trufero 2005 Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer J Clin Oncol. 23 34 8636 45
27. B Baujat C Amand F Eschwege 2004 Chemotherapy radiotherapy versus radiotherapy alone in nasopharynx carcinoma: preliminary results of a meta-analysis based on individual patient data Int J Radiat Oncol Biol Phys 60 191 2
28. JA Bonner PM Harari J Giralt 2006 Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck Engl J Med 354 6 567 78
29. SA Yeh Y Tang CC Lui 2005 Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone Int J Radiat Oncol Biol Phys 62 672 9